The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients

Journal of Clinical Oncology

Volumn 18, Issue 16, 2000, Pages 3038-3051

  Klastersky, Jean ^a   Paesmans, Marianne ^a   Rubenstein, Edward B ^a   Boyer, Michael ^a   Elting, Linda ^a   Feld, Ronald ^a   Gallagher, James ^a   Herrstedt, Jorn ^a   Rapoport, Bernardo ^a   Rolston, Kenneth ^a   Talcolt, James ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0033904644     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.16.3038     Document Type: Article

References (35)

1. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: Lessons from four EORTC trials
2. From the Infectious Diseases Society of America: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
3. Quantitative relationships between circulating leukocytes and infections in patients with acute myeloid leukemias
4. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients
5. Piperacillin/Tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
6. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials
7. Amikacin and ceftazidime as empirical therapy in severely neutropenic patients: Analysis of prognostic factors
8. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis
9. Factors associated with bacteremia in febrile granulocytopenic cancer patients
10. Infection risk factors in febrile neutropenic children and adolescents
11. Early infection in bone marrow transplantation: Quantitative study of clinical factors that affect risk
12. Early hospital discharge of children with cancer treated for fever and neutropenia: Identification and management of the low-risk patient
13. Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
14. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
15. Safety and cost-effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia
16. A pilot study of early hospital discharge in adult patients with fever and neutropenia
17. Stepdown single agent antibiotic therapy for the management of the high-risk neutropenic adult with hematologic malignancies
18. Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients
19. Oral versus intravenous empiric therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
20. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
21. Standards, options et recommendations pour la prise en charge des neutropenies courtes
22. National Comprehensive Cancer Network: NCCN practice guidelines for fever and neutropenia
23. The medical course of cancer patients with fever and neutropenia: Clinical identification of a low-risk subgroup at presentation
24. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule
25. Home antibiotic therapy for low-risk patients with fever and neutropenia: A pilot study of 30 patients based on a validated prediction rule
26. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial
27. Relating patient characteristics at the time of admission to outcomes of hospitalization
28. APACHE II: A severity of disease classification system
29. Multicenter outcome study of cancer patients admitted to the intensive care unit: A probability of mortality model
30. Assessing the generalizability of prognostic information
31. Predicting bacteremia in hospitalized patients: A prospectively validated model
32. Predicting the risk of bacteremia in children with fever and neutropenia
33. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies - International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)
34. Predicting bacteremia in patients with scpsis syndrome: Academic Medical Center Consortium Sepsis Project Working Group
35. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia